当前位置:首页 - 行情中心 - 华北制药(600812) - 财务分析 - 现金流量表

华北制药

(600812)

  

流通市值:105.52亿  总市值:105.52亿
流通股本:17.16亿   总股本:17.16亿

现金流量表

报告期2025-03-312024-12-312024-09-302024-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,543,655,921.957,556,833,074.365,594,132,346.93,702,753,296.2
收到的税费返还55,507,842.04105,991,573.592,584,407.6554,333,492.47
收到其他与经营活动有关的现金35,355,557.01198,454,535.84504,202,062.14535,591,311.14
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,634,519,3217,861,279,183.76,190,918,816.694,292,678,099.81
购买商品、接受劳务支付的现金668,605,567.423,294,331,239.882,604,852,414.661,742,928,867.72
支付给职工以及为职工支付的现金330,586,738.611,358,374,747.08977,258,465.26644,246,623.81
支付的各项税费97,446,478.87495,020,001.28333,320,080.79224,029,649.94
支付其他与经营活动有关的现金374,566,716.711,483,987,795.731,217,092,220.57798,290,158.42
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,471,205,501.616,631,713,783.975,132,523,181.283,409,495,299.89
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额163,313,819.391,229,565,399.731,058,395,635.41883,182,799.92
二、投资活动产生的现金流量:
取得投资收益收到的现金60,000,000710,914.98--
处置固定资产、无形资产和其他长期资产收回的现金净额6,9001,270,1711,256,5001,256,500
收到的其他与投资活动有关的现金-510,004,532.06--
投资活动现金流入的平衡项目0000
投资活动现金流入小计60,006,900511,985,618.041,256,5001,256,500
购建固定资产、无形资产和其他长期资产支付的现金120,585,892.86784,219,498.99481,875,355.35328,681,651.53
投资支付的现金-674,497,814.81--
投资活动现金流出的平衡项目0000
投资活动现金流出小计120,585,892.861,458,717,313.8481,875,355.35328,681,651.53
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-60,578,992.86-946,731,695.76-480,618,855.35-327,425,151.53
三、筹资活动产生的现金流量:
吸收投资收到的现金-903,000,000903,000,000900,000,000
其中:子公司吸收少数股东投资收到的现金-900,000,000--
取得借款收到的现金1,526,700,0009,793,745,0007,635,095,0004,851,475,000
收到其他与筹资活动有关的现金449,650,0001,004,700,416.67707,360,000707,360,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计1,976,350,00011,701,445,416.679,245,455,0006,458,835,000
偿还债务支付的现金1,267,968,397.939,622,872,723.136,971,652,723.134,264,160,325.2
分配股利、利润或偿付利息支付的现金94,467,339.65492,581,063.47391,688,722.05261,775,062.39
其中:子公司支付给少数股东的股利、利润23,514,00023,514,00022,102,00022,102,000
支付其他与筹资活动有关的现金600,950,493.881,123,254,659.131,602,772,467.481,576,756,614.6
筹资活动现金流出平衡项目0000
筹资活动现金流出小计1,963,386,231.4611,238,708,445.738,966,113,912.666,102,692,002.19
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额12,963,768.54462,736,970.94279,341,087.34356,142,997.81
四、汇率变动对现金及现金等价物的影响2,527,048.3711,828,701.558,067,852.118,662,566.74
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额118,225,643.44757,399,376.46865,185,719.51920,563,212.94
加:期初现金及现金等价物余额1,262,403,953.02505,004,576.56505,004,576.56505,004,576.56
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,380,629,596.461,262,403,953.021,370,190,296.071,425,567,789.5
补充资料:
净利润-214,966,518.33-97,495,559.68
资产减值准备-16,374,073.77--10,531,887.26
固定资产和投资性房地产折旧-635,679,352.84-313,947,674.18
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-635,679,352.84-313,947,674.18
无形资产摊销-157,305,834.77-68,215,137.49
长期待摊费用摊销-12,014,267.59-6,380,463
处置固定资产、无形资产和其他长期资产的损失--444,156.56--438,809.62
固定资产报废损失-136,209.76--
财务费用-458,698,019.11-238,700,837.64
投资损失--46,164,658.18--22,288,412.5
递延所得税-8,779,495.24--
其中:递延所得税资产减少--20,324,237.19--
递延所得税负债增加-29,103,732.43--
存货的减少-94,320,345.95-41,315,198.7
经营性应收项目的减少-377,130,760.26-75,986,483.94
经营性应付项目的增加--792,321,173.66-17,973,782.78
现金的期末余额-1,262,403,953.02-1,425,567,789.5
减:现金的期初余额-505,004,576.56-505,004,576.56
公告日期2025-04-242025-03-282024-10-262024-08-14
审计意见(境内)标准无保留意见
TOP↑